Skip to main content
XFOR
NASDAQ Life Sciences

X4 Pharmaceuticals Narrows Q3 Loss to 16c/Share, Cash at $187.7M

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$3.24
Mkt Cap
$321.235M
52W Low
$2.43
52W High
$4.83
52W Position info
33% above low
Off High info
33% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

XFOR sits 33% above its 52-week low of $2.43.

Summary

X4 posted a Q3 loss of 16 cents a share, narrowing the quarterly net loss to $20.2M from $29.8M a year earlier. The company ended September with $187.7M in cash and securities, a cushion that covers the 4WARD Phase 3 program and the recently restructured debt. The 10-Q filed minutes before this wire also spells out the October K2 HealthVentures refinancing, including a $15M convertible component, so the balance sheet now carries a $150M senior secured term loan. The quarter's story is spending discipline plus a funded pipeline rather than a revenue surprise — mavorixafor in chronic neutropenia remains pre-commercial. The FDA's September agreement to cut 4WARD enrollment from 176 to 126 patients keeps the trial timeline intact, and X4 expects the 4WARD enrollment target in Q4 2026; trial execution and enrollment are the items that will drive the stock from here.

At the time of this announcement, XFOR was trading at $3.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $321.2M. The 52-week trading range was $2.43 to $4.83. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

XFOR - Latest Insights

XFOR
Nov 04, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.24
Real-time Price: $3.00 info
Change: -$0.240 (-7%) info
Market Cap: $306.341M info
XFOR
Oct 29, 2026, 9:59 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.44
Real-time Price: $3.00 info
Change: -$0.440 (-13%) info
Market Cap: $306.341M info
XFOR
Oct 08, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $3.00 info
Change: +$0.1899 (+7%) info
Market Cap: $306.341M info
XFOR
Sep 08, 2026, 5:36 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.60
Real-time Price: $3.00 info
Change: -$0.600 (-17%) info
Market Cap: $306.341M info
XFOR
Sep 08, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.12
Real-time Price: $3.00 info
Change: -$1.12 (-27%) info
Market Cap: $306.341M info